Work

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate

Year: 2016

Type: article

Source: Nature Biotechnology

DOI: 10.1038/nbt.3697

Authors: Mark M Stevens, Cecile L Maire, Nigel Chou, Mark A Murakami, David S Knoff, Yuki Kikuchi, Robert J Kimmerling, Huiyun Liu, Samer Haidar, Nicholas L Calistri, Nathan Cermak, Selim Olcum, Nicolas A Cordero, Ahmed Idbaih, Patrick Y Wen, David M Weinstock, Keith L Ligon, Scott R Manalis

Institutions: Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Harvard University, Dana-Farber Cancer Institute, Hitachi High-Tech (Japan), Hitachi (Japan), Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut du Cerveau, Université Pierre-et-Marie-Curie, Center for Neuro-Oncology, Broad Institute, Brigham and Women's Hospital, Boston Children's Hospital

Language: English

Topic: Microfluidic and Bio-sensing Technologies

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences

Awards: Therapeutic Opportunities for Pediatric Astrocytoma, G1547207268, Graduate Training in Computational and Systems Biology, Interdepartmental Biotechnology Training Program, The MIT Center for Single-Cell Dynamics in Cancer (SCDC), G3556728958, G4354213545, G458629407, G6671539959, Stochastic gene expression in differentiation and development, Cancer Center Support (Core) Grant, Targeted Therapies for Glioma, G920764344, Single cell growth assay for residual cells in acute lymphoblastic leukemia

OpenAlex ID: W2530955838

FWCI: 6.081

Cites: 31

Cited by: 105

Related to: 10